Cargando…
Optimized spirooxindole-pyrazole hybrids targeting the p53-MDM2 interplay induce apoptosis and synergize with doxorubicin in A549 cells
Recently, cancer research protocols have introduced clinical-stage spirooxindole-based MDM2 inhibitors. However, several studies reported tumor resistance to the treatment. This directed efforts to invest in designing various combinatorial libraries of spirooxindoles. Herein, we introduce new series...
Autores principales: | Islam, Mohammad Shahidul, Al-Majid, Abdullah Mohammed, Sholkamy, Essam Nageh, Barakat, Assem, Viale, Maurizio, Menichini, Paola, Speciale, Andrea, Loiacono, Fabrizio, Azam, Mohammad, Verma, Ved Prakash, Yousuf, Sammer, Teleb, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167355/ https://www.ncbi.nlm.nih.gov/pubmed/37156796 http://dx.doi.org/10.1038/s41598-023-31209-3 |
Ejemplares similares
-
Construction of Spirooxindole Analogues Engrafted
with Indole and Pyrazole Scaffolds as Acetylcholinesterase Inhibitors
por: Islam, Mohammad Shahidul, et al.
Publicado: (2021) -
Stereoselective Synthesis of the Di-Spirooxindole Analogs Based Oxindole and Cyclohexanone Moieties as Potential Anticancer Agents
por: Al-Majid, Abdullah Mohammed, et al.
Publicado: (2021) -
Design, Synthesis, Chemical and Biochemical Insights Into Novel Hybrid Spirooxindole-Based p53-MDM2 Inhibitors With Potential Bcl2 Signaling Attenuation
por: Aziz, Yasmine M. Abdel, et al.
Publicado: (2021) -
Substituted spirooxindole derivatives as potent anticancer agents through inhibition of phosphodiesterase 1
por: Barakat, Assem, et al.
Publicado: (2018) -
Synthesis and Characterization of New Spirooxindoles Including Triazole and Benzimidazole Pharmacophores via [3+2] Cycloaddition Reaction: An MEDT Study of the Mechanism and Selectivity
por: Alshahrani, Saeed, et al.
Publicado: (2023)